Aardvark Therapeutics, Inc. Common Stock
Aardvark Therapeutics, Inc. Common Stock（AARD）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
aard · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$47.00
Consensus
$22.75
+533.7% upside
Low
$3.00
Median: $20.5 · Last Close: $3.59
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$22.75
533.7% upside
High Target
$47
1209.2%
Low Target
$3
-16.4%
Current Price
$3.59
as of today
Based on analyst price targets, the AARD stock price prediction for the next 12 months ranges from $3 to $47. The consensus AARD price forecast of $22.75 implies 533.7% upside from the current price of $3.59.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.41 | ↓ 5.00% |
1-day model range: $3.35–$3.47. Peak: $3.47 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AARD · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Morgan Stanley | Downgrade ↓ | Equal Weight→Underweight |
| 2026-05-15 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2026-05-15 | B. Riley Securities | Maintains | Buy→Buy |
| 2026-03-24 | BTIG | Maintains | Buy→Buy |
| 2026-03-02 | BTIG | Maintains | Buy→Buy |
| 2026-03-02 | Morgan Stanley | Downgrade ↓ | Overweight→Equal Weight |
| 2026-03-02 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2026-03-02 | Stifel | Downgrade ↓ | Buy→Hold |
| 2026-03-02 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-03-02 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Aardvark Therapeutics, Inc. Common Stock (AARD) stock. Of the recent 20 rating actions, 0 were upgrades and 6 were downgrades. 9 analysts currently cover AARD.
分析师推荐趋势
AARD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 95.5% YoY
Revenue Next Year
$1M
↑ 242.0% YoY
EPS This Year
$-3.59
EPS Next Year
$-3.26
↓ 9.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast AARD EPS of $-3.59 for the current fiscal year, based on estimates from 9 analysts. The AARD revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AARD 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AARD 的共识目标价为 $22.75（+533.7% 上行空间），分析师共识为 Buy。
AARD 的短期预测（明日）为 $3.41（-5.00%）。
Aardvark Therapeutics, Inc. Common Stock 在 NASDAQ 上市，代码 AARD。AARD 在 2027 年的整体展望偏积极，在覆盖分析师中约 44% 对应 Buy 共识。
常见问题
AARD 预测 · 8 个问题根据 9 位华尔街分析师，AARD 的 12 个月平均目标价为 $22.75，最高 $47.00、最低 $3.00。若有图表，中位目标价可在上方查看。相对当前价 $3.59，隐含约 +533.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.